Malika Khodjaeva

5 та иш

Tashkent Medical Academy

1. The medical impact of hepatitis D virus infection in Uzbekistan

   Malika Khodjaeva, Nargiz Ibadullaeva, Aziza Khikmatullaeva +6

   МақолаHepatitis B Virus StudiesLiver International20193 иқтибос

   ABIABI:AkademIndex/openalex/2019.article.000123

2. MicroRNA-122: assessment of diagnostic significance in HDV infection

   Malika Khodjaeva, Aziza Khikmatullaeva, Nargiz Ibadullaeva +3

   МақолаMicroRNA in disease regulationJournal Infectology20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.article.005658

3. Hepatitis B and C landscape in Uzbekistan: epidemiological patterns revealed in a study of 1 040 000 people

   Umed Ismoilov, Erkin Musabaev, Aziza Khikmatullaeva +13

   МақолаHepatitis B Virus StudiesEuropean Journal of Public Health20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.007997

4. Comparative analysis of non-invasive fibrosis markers: Insights from chronic HBV, HBV+HDV, and HCV infections

   Aziza Saydullaevna Khikmatullaeva, Krestina Stepanovna Brigida, Nargiza Mirzakhidovna Мirrakhimova +7

   МақолаLiver Disease Diagnosis and TreatmentInfectious Medicine20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.010427

5. Prevalence and epidemiology of hepatitis B and hepatitis D in Uzbekistan—results from a population-based serosurvey, 2022

   Erkin Musabaev, Rania A. Tohme, Elizaveta Joldasova +11

   МақолаHepatitis B Virus StudiesIJID Regions20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.014949